当前位置: X-MOL 学术J. Biochem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
MicroRNA-760 inhibits cell viability and migration through down-regulating BST2 in gastric cancer.
The Journal of Biochemistry ( IF 2.7 ) Pub Date : 2020-03-13 , DOI: 10.1093/jb/mvaa031
Weiyu Liu 1 , Yan Li 1 , Shuting Feng 1 , Yadi Guan 2 , Yong Cao 2
Affiliation  

Gastric cancer is one of the most common types of carcinoma with a threat to global health. MicroRNA-760 (miR-760) was significantly down-regulated in the primary tumour of patients with advanced gastric cancer. However, the role of miR-760 in gastric cancer is still unclear. Herein, miR-760 was down-regulated in gastric cancer tissues. Moreover, miR-760 overexpression and knockdown were conducted in gastric cancer cells (MGC-803 and SGC-7901) in vitro. The in vitro functional assays proved that miR-760 overexpression reduced cell viability, cell cycle, migration and invasion, promoted apoptosis and suppressed MMP activity in MGC-803 cells. Conversely, miR-760 knockdown led to the opposite in SGC-7901 cells. Notably, bone marrow stromal antigen 2 (BST2) was verified as a target gene of miR-760. MiR-760 mimics down-regulated BST2 level in gastric cancer tissues and in MGC-803 cells, whereas miR-760 inhibitor up-regulated its level in SGC-7901 cells. MiR-760-regulated cell properties through reduction of BST2. In addition, miR-760 inhibited tumourigenesis in a nude mouse xenograft model in vivo. In conclusion, our results demonstrated that miR-760 exhibited a suppressive role in gastric cancer via inhibiting BST2, indicating that miR-760/BST2 axis may provide promising therapeutic target for gastric cancer.

中文翻译:

MicroRNA-760通过下调胃癌中的BST2抑制细胞活力和迁移。

胃癌是威胁全球健康的最常见癌症之一。MicroRNA-760(miR-760)在晚期胃癌患者的原发肿瘤中显着下调。但是,miR-760在胃癌中的作用仍不清楚。在本文中,miR-760在胃癌组织中被下调。此外,在胃癌细胞(MGC-803和SGC-7901)进行了miR-760的过表达和敲低。在体外功能测定证明,miR-760过表达降低了MGC-803细胞的细胞活力,细胞周期,迁移和侵袭,促进了细胞凋亡并抑制了MMP活性。相反,miR-760的敲低导致SGC-7901细胞的情况相反。值得注意的是,已证实骨髓基质抗原2(BST2)是miR-760的靶基因。MiR-760模仿了胃癌组织和MGC-803细胞中BST2的下调,而miR-760抑制剂却在SGC-7901细胞中上调了BST2的水平。通过减少BST2,MiR-760调节细胞特性。此外,miR-760在体内抑制裸鼠异种移植模型中的肿瘤发生。总之,我们的结果表明miR-760通过抑制BST2在胃癌中具有抑制作用,表明miR-760 / BST2轴可能为胃癌提供有希望的治疗靶点。
更新日期:2020-03-13
down
wechat
bug